Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 26, Issue 22, pp. 5843-5851
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 5, 2020
- Revision received June 22, 2020
- Accepted August 14, 2020
- Published first August 25, 2020.
Article Versions
- Previous version (August 25, 2020 - 05:56).
- Previous version (October 8, 2020 - 06:49).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Valentina Guarneri1,2,
- Maria Vittoria Dieci1,2,*,
- Giancarlo Bisagni3,
- Alba A. Brandes4,
- Antonio Frassoldati5,
- Luigi Cavanna6,
- Antonino Musolino7,8,
- Francesco Giotta9,
- Anita Rimanti10,
- Ornella Garrone11,
- Elena Bertone12,
- Katia Cagossi13,
- Oriana Nanni14,
- Federico Piacentini15,
- Enrico Orvieto16,
- Gaia Griguolo1,2,
- Matteo Curtarello17,
- Loredana Urso1,
- Laia Paré18,
- Nuria Chic19,20,
- Roberto D'Amico21,22,
- Aleix Prat18,19,20, and
- Pierfranco Conte1,2
- 1Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
- 2Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
- 3Department of Oncology and Advanced Technologies, Reggio Emilia, Italy.
- 4Medical Oncology, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy.
- 5Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S Anna University Hospital, Ferrara, Italy.
- 6Department of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
- 7Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
- 8Department of Medicine and Surgery, University of Parma, Parma, Italy.
- 9IRCCS Istituto Tumori “Giovanni Paolo II” di Bari, Parma, Italy.
- 10Medical Oncology, Azienda Ospedaliera di Mantova, Mantova, Italy.
- 11Breast Unit, Medical Oncology, A.O.S. Croce and Carle Teaching Hospital, Cuneo, Italy.
- 12Department of Gynecology and Obstetrics, Ospedale S. Anna, Turin, Italy.
- 13Breast Unit Ausl Modena, Ramazzini Hospital, Carpi, Italy.
- 14Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
- 15Division of Medical Oncology, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena, Italy.
- 16Pathology Unit, Rovigo, Italy.
- 17Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
- 18SOLTI Breast Cancer Research Group, Barcelona, Spain.
- 19Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
- 20Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
- 21Department of Medical and Surgical Sciences for Children & Adults, University of Modena, Modena, Italy.
- 22Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
- ↵*Corresponding Author:
Maria Vittoria Dieci, University of Padova, Istituto Oncologico Veneto IRCCS, via Gattamelata 64, Padova 35128, Italy. Phone: 39 0498215295; Fax: 39 0498215932; E-mail: mariavittoria.dieci{at}unipd.it
November 2020
Volume 26, Issue 22
Volume 26, Issue 22
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype
Jump to section
Advertisement